Author: elena comino Date: 10/10/2007
RAR and RXR modulation in cancer and metabolic disease.
A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocyte stage.
CaMKII regulates retinoic acid receptor transcriptional activity and the differentiation of myeloid leukemia cells
Induction of Differentiation of the Human Promyelocytic Leukemia Cell Line (HL-60) by Retinoic Acid
Myeloid differentiation mediated through retinoic acid receptor/retinoic X receptor (RXR) not RXR/RXR pathway
Regulation of progranulin expression in myeloid cells
The Retinoic Acid-responsive Proline-rich Protein Is Identified in Promyeloleukemic HL-60 Cells
The unhydrolyzable fenretinide analogue 4-hydroxybenzylretinone induces the proapoptotic genes GADD153 (CHOP) and Bcl-2-binding component 3 (PUMA) and apoptosis that is caspase- dependent and independent of the retinoic acid receptor.
